Cyclic variations of SR 233377 (WIN 33377) and effects on antitumor activity

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 12, 1996, Pages 1345-1350

  Wentland, Mark P ^a,c   Perni, Robert B ^a,d   Huang, Jianhua I ^a   Powles, Ronald G ^a   Aldous, Suzanne C ^a   Klingbeil, Kristina M ^a   Peverly, A Danielle ^a   Robinson, Ronald G ^a   Corbett, Thomas H ^b   Jones, Julie L ^b   Rake, James B ^a   Coughlin, Susan A ^a  

^a EASTMAN KODAK COMPANY   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c Research Rensselaer Polytechnic Institute   (United States)

^d Avid Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; DOXORUBICIN; GYRASE INHIBITOR; N [[1 [[2 (DIETHYLAMINO)ETHYL]AMINO] 9 OXO 9H THIOXANTHEN 4 YL]METHYL]METHANESULFONAMIDE; PYRAZOLONE DERIVATIVE; SR 233377; THIOXANTHENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CYTOTOXICITY; DOSE RESPONSE; DRUG STRUCTURE; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA CELL; MOUSE; NONHUMAN; SOLID TUMOR; STRUCTURE ACTIVITY RELATION;

EID: 0029941558     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00230-2     Document Type: Article

References (14)

1. Wentland, M. P.; Perni, R. B.; Huang, J. I.; Powles, R. G.; Aldous, S. C.; Klingbeil, K. M.; Peverly, A. D.; Robinson, R. G.; Corbett, T. C.; Rake, J. B.; Coughlin, S. A. Proceedings of the Eighty-sixth Annual Meeting of American Association for Cancer Research, Toronto, Canada, March 18-22, 1995, Abstr. 2289.
2. Wentland, M. P.; Perni, R. B.; Powles, R. G.; Hlavac, A. G.; Mattes, K. C.; Corbett, T. H.; Coughlin, S. A.; Rake, J. B. Bioorg. Med. Chem. Lett. 1994, 4, 609.
3. Showalter, H. D. H.; Johnson, J. L.; Hoftiezer, J. M.; Turner, W. R.; Werbel, L. M.; Leoplold, W. R.; Shillis, J. L.; Jackson, R. C.; Elslager, E. F. J. Med. Chem. 1987, 30, 121.
4. Capps, D. B.; Dunbar, J.; Kesten, S. R.; Shillis, J.; Werbel, L. M.; Plowman, J.; Ward, D. L. J. Med. Chem. 1992, 35, 4770.
5. Showalter, H. D. H.; Angelo, M. M.; Berman, E. M.; Kanter, G. D.; Ortwine, D. F.; Ross-Kesten, S. G.; Sercel, A. D.; Turner, W. R.; Werbel, L. M.; Worth, D. F.; Elslager, E. F.; Leopold, W. R.; Shillis, J. L. J. Med. Chem. 1988, 31, 1527.
6. Laidlaw, G. M.; Collins, J. C.; Archer, S.; Rosi, D.; Schulenberg, J. W. J. Org. Chem. 1973, 38, 1743.
7. Archer, S.; Zayed, A.-H.; Rej, R.; Rugino, T. A. J. Med. Chem. 1983, 26, 1240.
8. Rieche, A.; Gross, H.; Höft, E. Chem. Ber. 1960, 93, 88.
9. Coughlin, S. C.; Danz, D. W.; Robinson, R. G.; Klingbeil, K. M.; Wentland, M. P.; Corbett, T. H.; Waud, W. R.; Zwelling, L. A.; Altschuler, E.; Bales, E.; Rake, J. B. Biochem. Pharmacol. 1995, 50, 111.
10. Cain, B. F.; Baguley, B. C.; Denny, W. A. J. Med. Chem. 1978, 21, 658.
11. Pommier, Y.; Minford, J. K.; Schwartz, R. E.; Zwelling, L. A.; Kohn, K. W. Biochemistry 1985, 24, 6410.
12. Corbett, T. H.; Valeriote, F. A.; Polin, L.; Panchapor, C.; Pugh, S.; White, K.; Lowichik, N.; Knight, J.; Bissery, M.-C.; Wozniak, A.; LoRusso, P.; Biernat, L.; Polin, D.; Knight, L.; Biggar, S.; Looney, D.; Demchik, L.; Jones, J.; Jones, L.; Blair, S.; Palmer, K.; Essenmacher, S.; Lisow, L.; Mattes, K. C.; Cavanaugh, P. F.; Rake, J. B.; Baker, L. Cytotoxic Anticancer Drugs: Models and Concepts for Drug Discovery and Development; Valeriote, F. A.; Corbett, T. H.; Baker, L. H., Eds.; Kluwer Academic: Boston, 1992, pp 35-87.
13. Corbett, T. H.; Roberts, B. J.; Leopold, W. R.; Peckham, J. C.; Wilkoff, L. J.; Griswold, D. P., Jr.; Schabel, F. M., Jr. Cancer Res. 1984, 44, 111.
14. LoRusso, P.; Wozniak, A. J.; Polin, L.; Capps, D.; Leopold, W. R.; Werbel, L. M.; Biernat, L.; Dan, M. E.; Corbett, T. H. Cancer Res. 1990, 50, 4900.